Filing Details
- Accession Number:
- 0000950170-23-040463
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-08-09 15:07:24
- Reporting Period:
- 2023-08-07
- Accepted Time:
- 2023-08-09 15:07:24
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1088856 | Corcept Therapeutics Inc | CORT | Pharmaceutical Preparations (2834) | 770487658 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1323113 | Jr N Daniel Swisher | C/O Corcept Therapeutics Incorporated 149 Commonwealth Drive Menlo Park CA 94025 | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2023-08-07 | 2,200 | $6.55 | 2,200 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2023-08-07 | 650 | $5.86 | 2,850 | No | 4 | M | Direct | |
Common Stock | Disposition | 2023-08-07 | 2,200 | $30.14 | 650 | No | 4 | S | Direct | |
Common Stock | Disposition | 2023-08-07 | 650 | $30.16 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock option (right to buy) | Disposition | 2023-08-07 | 2,200 | $0.00 | 2,200 | $6.55 |
Common Stock | Stock option (right to buy) | Disposition | 2023-08-07 | 650 | $0.00 | 650 | $5.86 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
5,300 | 2025-06-18 | No | 4 | M | Direct | |
49,350 | 2026-07-21 | No | 4 | M | Direct |
Footnotes
- Fully exercisable.